This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program
Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020,
Today, Astra-Zeneca joined other manufacturers in announcing that it would no longer honor all contract pharmacy arrangements. Astra-Zeneca sent letters to 340B covered entities informing
On July 29, Reps. Doris Matsui (D-CA) and Chris Stewart (R-UT) introduced a bill that would protect 340B hospitals from losing their covered entity status
The Court of Appeals for District of Columbia Circuit issued a 2-1 decision today upholding Medicare Part B reimbursement cuts for 340B drugs from ASP+6%
On Friday, July 24, President Donald Trump signed four Executive Orders designed to lower the cost of prescription drugs. This alert will focus on three
Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate
Washington, D.C. – Shannon Stephenson, president of RWC-340B, said, “The White House Executive Orders related to 340B set a very dangerous precedent at the worst
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP
Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy
The US Conference on HIV/AIDS (USCHA) announced that this year’s conference will be held virtually on October 19-21, 2020. Registration is free for the first
